🇺🇸 FDA
Pipeline program

Study of GS-0151 in Participants With Rheumatoid Arthritis

GS-US-667-6882

Phase 1 other active

Quick answer

Study of GS-0151 in Participants With Rheumatoid Arthritis for Rheumatoid Arthritis is a Phase 1 program (other) at Gilead Sciences International Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences International Limited
Indication
Rheumatoid Arthritis
Phase
Phase 1
Modality
other
Status
active

Clinical trials